Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped positive-stranded RNA virus and the causative agent of COVID-19, a primarily respiratory illness characterized by fever, cough, and shortness of breath that can lead to life-threatening complications.1,2,3,4,5 The SARS-CoV-2 genome contains approximately 30 kilobases and 14 open reading frames (ORFs) that encode four structural proteins: spike, envelope, membrane, and nucleocapsid, as well as 16 non-structural proteins and 9 accessory factors.6 SARS-CoV-2 non-structural protein 8 (nsp8) is encoded within ORF1ab and is a cofactor and component of the SARS-CoV-2 decameric RNA replication transcriptional complex. It functions as an anchoring scaffold for the RNA transcription complex, with its N-terminal domain (NTD) binding to the RNA-dependent polymerase (RdRp) nsp12, the helicase nsp13, and RNA.7 SARS-CoV-2 nsp8 also functions as a virulence factor, binding to the host 7SL RNA component of the signal recognition particle to suppress membrane protein trafficking and impair host antiviral responses.8
WARNING This product is not for human or veterinary use.
1. From SARS and MERS CoVs to SARS-
2. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395(10224), 565-574 (2020).
3. Novel coronavirus 2019-
4. Incidence of thrombotic complications in critically ill ICU patients with COVID-
5. Analysis of 92 deceased patients with COVID-
6. A structural view of SARS-
7. SARS-
8. SARS-